K+S Raises 2026 Earnings Outlook After Strong Q1 Results 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
Malaysia Unveils Energy Security Plan Amid Iran Conflict and Rising Oil Costs 
Dollar Struggles to Rally Despite Strong US Data as Fed Hike Expectations Remain Limited 
Asian Stocks Rise Despite Middle East Tensions as Chipmakers Boost Markets 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Oil Prices Rise Amid Strait of Hormuz Tensions and U.S.-Iran Ceasefire Uncertainty 
Armani Group Eyes Strategic Stake Sale to Luxury Giants 
Asian Currencies Slide as Iran Tensions Boost Dollar and Oil Prices 
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit 
Oil Prices Surge Over 3% as Trump Rejects Iran Peace Response 
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income 
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts 
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
